MedPath
NMPA Approval

五子衍宗丸

国药准字Z41020225

September 30, 2021

国药准字Z41020225

Drug Information

五子衍宗丸

君山

丸剂

36g/瓶、60g/瓶

中药

September 30, 2021

Company Information

Applicant Company

河南省洛阳市栾川县城君山东路

Manufacturing Company

河南省洛阳市栾川县城君山东路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

五子衍宗丸 - NMPA 批准文号 | MedPath